Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epigenetic Modifications and Head and Neck Cancer: Implications for Tumor Progression and Resistance to Therapy
Rogério M. Castilho, Cristiane H. Squarize, Luciana O. Almeida
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 7, pp. 1506-1506
Open Access | Times Cited: 152

Showing 26-50 of 152 citing articles:

Systems Biology Approaches and Precision Oral Health: A Circadian Clock Perspective
Henry A. Adeola, Silvana Papagerakis, Pétros Papagerakis
Frontiers in Physiology (2019) Vol. 10
Open Access | Times Cited: 30
SIRT1: a potential tumour biomarker and therapeutic target
Bin Zhao, Xin Li, Liangfu Zhou, et al.
Journal of drug targeting (2019) Vol. 27, Iss. 10, pp. 1046-1052
Closed Access | Times Cited: 30
Liquid biopsy in head and neck squamous cell carcinoma: circulating tumor cells, circulating tumor DNA, and exosomes
Wen-Ying Yang, Linfei Feng, Xiang Meng, et al.
Expert Review of Molecular Diagnostics (2020) Vol. 20, Iss. 12, pp. 1213-1227
Closed Access | Times Cited: 28
Cytotoxic Effects of 5-Azacytidine on Primary Tumour Cells and Cancer Stem Cells from Oral Squamous Cell Carcinoma: An In Vitro FTIRM Analysis
Valentina Notarstefano, Alessia Belloni, Simona Sabbatini, et al.
Cells (2021) Vol. 10, Iss. 8, pp. 2127-2127
Open Access | Times Cited: 26
Epithelial-to-Mesenchymal Transition-Derived Heterogeneity in Head and Neck Squamous Cell Carcinomas
Philipp Baumeister, Jiefu Zhou, Martin Canis, et al.
Cancers (2021) Vol. 13, Iss. 21, pp. 5355-5355
Open Access | Times Cited: 24
Electroporation in Head-and-Neck Cancer: An Innovative Approach with Immunotherapy and Nanotechnology Combination
Silvia Pisani, Giulia Bertino, Adriele Prina‐Mello, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5363-5363
Open Access | Times Cited: 17
Role of epigenetics in OSCC: an understanding above genetics
Priyanka P. Vatsa, Yogita Jindal, Janhavi Bhadwalkar, et al.
Medical Oncology (2023) Vol. 40, Iss. 4
Closed Access | Times Cited: 10
Immunohistochemical Expression of DAPK-1 in Oral Leukoplakia And Oral Squamous Cell Carcinoma: A Preliminary Study
Petros Papadopoulos, Vasileios Zisis, Dimitrios Andreadis, et al.
Cureus (2025)
Open Access
Pharmacology of Epitranscriptomic Modifications: Decoding the Therapeutic Potential of RNA Modifications in Drug Resistance
Abdullah Alkhammash
European Journal of Pharmacology (2025) Vol. 994, pp. 177397-177397
Closed Access
Investigation of the Molecular Mechanisms of Paraoxonase‐2 Mediated Radiotherapy and Chemotherapy Resistance in Oral Squamous Cell Carcinoma
Mehta Vedant Kamal, Krishnananda Prabhu, Krishna Sharan, et al.
Clinical and Translational Science (2025) Vol. 18, Iss. 4
Open Access
SUZ12 is a novel putative oncogene promoting tumorigenesis in head and neck squamous cell carcinoma
Yaping Wu, Huijun Hu, Wei Zhang, et al.
Journal of Cellular and Molecular Medicine (2018) Vol. 22, Iss. 7, pp. 3582-3594
Open Access | Times Cited: 30
Analysis of methylation‐driven genes for predicting the prognosis of patients with head and neck squamous cell carcinoma
Yihua Pan, Yidan Song, Lanxin Cheng, et al.
Journal of Cellular Biochemistry (2019) Vol. 120, Iss. 12, pp. 19482-19495
Closed Access | Times Cited: 27
Valproic Acid Synergizes With Cisplatin and Cetuximab in vitro and in vivo in Head and Neck Cancer by Targeting the Mechanisms of Resistance
Federica Iannelli, Andrea Ilaria Zotti, Maria Serena Roca, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 26
Senescence Induction by Combined Ionizing Radiation and DNA Damage Response Inhibitors in Head and Neck Squamous Cell Carcinoma Cells
Clara Dobler, Tina Jost, Markus Hecht, et al.
Cells (2020) Vol. 9, Iss. 9, pp. 2012-2012
Open Access | Times Cited: 26
Anaerobic bacterial communities associated with oral carcinoma: Intratumoral, surface-biofilm and salivary microbiota
János Minárovits
Anaerobe (2020) Vol. 68, pp. 102300-102300
Closed Access | Times Cited: 25
The Emerging Significance of Histone Lysine Demethylases as Prognostic Markers and Therapeutic Targets in Head and Neck Cancers
Dawid Dorna, Jarosław Paluszczak
Cells (2022) Vol. 11, Iss. 6, pp. 1023-1023
Open Access | Times Cited: 15
High levels of Histone H3 K27 acetylation and tri-methylation are associated with shorter survival in Oral Squamous Cell Carcinoma patients
Akram Shahhosseini, Ekaterina Bourova-Flin, Samira Derakhshan, et al.
Biomedicine (2023) Vol. 13, Iss. 1, pp. 22-38
Open Access | Times Cited: 9
Genome-wide DNA methylation profiling of HPV-negative leukoplakia and gingivobuccal complex cancers
Mayuri Inchanalkar, Sumana Srivatsa, Srikant Ambatipudi, et al.
Clinical Epigenetics (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 9
Combined class I histone deacetylase and mTORC1/C2 inhibition suppresses the initiation and recurrence of oral squamous cell carcinomas by repressing SOX2
Xueyi Liang, Miao Deng, Chi Zhang, et al.
Cancer Letters (2019) Vol. 454, pp. 108-119
Closed Access | Times Cited: 23
Macrophage‑derived exosomes attenuate the susceptibility of oral squamous cell carcinoma cells to chemotherapeutic drugs through the AKT/GSK‑3β pathway
Riki Tomita, Eri Sasabe, Ayumi Tomomura, et al.
Oncology Reports (2020)
Open Access | Times Cited: 23
Entinostat is a novel therapeutic agent to treat oral squamous cell carcinoma
Ana Elizia Mascarenhas Marques, Carlos Filho, Thâmara Manoela Marinho Bezerra, et al.
Journal of Oral Pathology and Medicine (2020) Vol. 49, Iss. 8, pp. 771-779
Open Access | Times Cited: 21
Salivary DNA Methylation as an Epigenetic Biomarker for Head and Neck Cancer. Part I: A Diagnostic Accuracy Meta-Analysis
Óscar Rapado‐González, Cristina Martínez‐Reglero, Ángel Salgado‐Barreira, et al.
Journal of Personalized Medicine (2021) Vol. 11, Iss. 6, pp. 568-568
Open Access | Times Cited: 18
KIR2DS1 , 2DS5 , 3DS1 and KIR2DL5 are associated with the risk of head and neck squamous cell carcinoma in Iranians
Shaghik Barani, Bijan Khademi, Elham Ashouri, et al.
Human Immunology (2018) Vol. 79, Iss. 4, pp. 218-223
Closed Access | Times Cited: 23
Histone modifications in oral squamous cell carcinoma and oral potentially malignant disorders
Huamei Yang, Xin Jin, Hongxia Dan, et al.
Oral Diseases (2019) Vol. 26, Iss. 4, pp. 719-732
Closed Access | Times Cited: 22
Interference with the bromodomain epigenome readers drives p21 expression and tumor senescence
Liana Preto Webber, Veronica Quispe Yujra, Pablo Agustín Vargas, et al.
Cancer Letters (2019) Vol. 461, pp. 10-20
Open Access | Times Cited: 20

Scroll to top